Press Releases - Current

Prostate Cancer Foundation Partners with AACR to Recognize Promising Young Cancer Researchers
Awardees Honored at AACR Annual Meeting 2008

Philadelphia, PA, April 24, 2008 – The American Association for Cancer Research (AACR) is pleased to announce a new partnership with the Prostate Cancer Foundation, creating the AACR-Prostate Cancer Foundation Recognition Awards for Research Excellence. Recently given at the AACR Annual Meeting 2008, the awards provide financial support for early-career scientists to travel to AACR scientific meetings to present exceptional proffered papers in the field of translational prostate cancer research.

Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration
S.T.A.R. Program Brings Together Researchers from North America's Leading Prostate Cancer Centers

Washington, DC, November 15, 2007 – Safeway Inc. and the Prostate Cancer Foundation today announced they will collectively donate $6 million to fund the S.T.A.R. Program (for Special Team Amplification of Research), an innovative research initiative focused on exploring the role of targeted heat in cancer therapy to treat prostate cancer, as well as other research strategies.

Leading Researchers to Reveal Comprehensive Dos and Don'ts for Prostate Cancer
Avoiding Prostate Cancer and Living Better after Diagnosis Subject of "Lifestyle" Panel

Lake Tahoe, CA, October 13, 2007 – Lake Tahoe, CA, October 13, 2007–Today at the Prostate Cancer Foundation's Annual Scientific Retreat, researchers will share new findings on how eating common foods such as tomatoes and fish, maintaining a healthy weight, and avoiding meats cooked at high temperatures may help prevent prostate cancer, and help men live healthier and longer after diagnosis.  One in six men will be diagnosed with prostate cancer in their lifetime, and an estimated 218,890 cases will occur in The United States this year.

David H. Koch – Prostate Cancer Foundation Nano-Medicine Gift Announced
$5 Million Award Creates Collaborative Team Across Four Leading Research Institutions

Lake Tahoe, CA, October 12, 2007 – One of the largest-ever individual donations for prostate cancer research will unite researchers across institutions and disciplines in the field of nanotechnology. This research team, created by the Prostate Cancer Foundation, will seek to develop a novel nano-medicine that can be given intravenously and delivered directly to targeted prostate tumors. The five million dollar gift by philanthropist and business leader David H. Koch was announced at the Foundation's Annual Scientific Retreat.

New Molecules Discovered that Block Cancer Cells from Modifying Cell DNA

Lake Tahoe, CA, October 11, 2007 – Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications. The findings were presented today at the Prostate Cancer Foundation's annual Scientific Retreat. Funding for the research was provided by the Prostate Cancer Foundation, as well as from the National Cancer Institute and the Avon Foundation. 

New Research May Show Why Some Prostate Cancer Recurs After Treatment
Cancer Cells Contain Building Blocks for Cancer "Fuel"

Lake Tahoe, CA, October 11, 2007 – Cancer researchers have long worked to understand why some prostate cancers recur after the use of therapies designed to stop the production of testosterone and other androgens that fuel cancer cell growth. New research has now detected that androgen-synthesizing proteins are present within cancer cells, which suggests that cancer cells may develop the capacity to produce their own androgens.

New Genetic Cause Identified in Prostate Cancer Development
Research Studies Funded by Prostate Cancer Foundation Help Find a Master "On" Switch for Prostate Cancer
 
SANTA MONICA, Calif., August 6, 2007 – Data from a new study implicates a specific genetic change as an underlying cause of prostate cancer development, according to a report published August 1, 2007, in Nature. The finding revealed that prostate cancer really is a set of different cancers that are "turned on" by a common "master switch" gene.

Archive
All 2008 press releases
2007 press releases
2006 press releases
2005 press releases
2004 press releases
2003 press releases